In association with Maximising manufacturing How can companies overcome the manufacturing challenges hindering the revolutionary potential of gene and cell therapies? ISSUE 75 I OCTOBER 2018 Making the most of biomarkers Clinical trial transparency in the Americas AI generated compounds 06/06/2019 17:09:40